-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Mirati Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2012 to Q3 2023.
- Mirati Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
- Mirati Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $508K, a 84.6% decline from 2021.
- Mirati Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $3.3M.
- Mirati Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)